Besides the cancer cell invasion, different TP53 mutants may exert a variety of gain-of-function including drug resistance.24,68 Drug resistance is an important factor that influences the overall survival of patients.69 BCAR1 is also known to promote drug resistance.37,45 Therefore, the underlying mechanisms of how these interactions affect patient survival remain to be investigated. Here, BCAR1 is linked to cancer.